Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-29 · accession 0001367644-24-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-31 | 2024-05-29 | EBS | Zoon Kathryn C | Dir | S - Sale | $4.61 | -1,830 | 64.5K | -3% | -$8,436 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-29 | S | D | 1,830 | $4.61 | 64,482 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a grandfathered trading plan adopted by Ms. Zoon on June 15, 2022. |